FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery
ImmunityBio therapy Anktiva is now FDA approved for treating patients with non-muscle invasive bladder cancer. The novel immunotherapy works by sparking activity from three types of immune cells.